Phase 3 Dry Eye Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Dry Eye Disease (DED)
Oculis160 enrolled10 locationsNCT07548632
Recruiting
Phase 3
A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
Moderate to Severe Dry Eye
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.360 enrolled1 locationNCT06766357
Recruiting
Phase 3
Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
Dry Eye Disease (DED)
Lunan Better Pharmaceutical Co., LTD.820 enrolled1 locationNCT06879782
Recruiting
Phase 3
Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease
Dry Eye
VivaVision Biotech, Inc700 enrolled1 locationNCT06360133
Recruiting
Phase 3
Cyclosporine and Intense Pulsed Light for Dry Eye in Contact Lens Users
Dry EyeContact Lens Complication
Université de Sherbrooke44 enrolled1 locationNCT06392438
Recruiting
Phase 3
Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients
Dry Eye Syndromes
AJU Pharm Co., Ltd.396 enrolled1 locationNCT06291194
Completed
Phase 3
Dietary supplements and ocular (eye) comfort
Ocular comfort including symptoms of dry eye
Blackmores Limited80 enrolled1 locationACTRN12610000991011